A groundbreaking discovery has recently brought hope to millions of people living with type 1 diabetes around the world. In a ...

In a medical breakthrough, a 25-year-old woman from China achieved insulin independence through a pioneering stem cell procedure that could transform the treatment landscape for type 1 diabetes. This ...

'It is established that replacement islets can free a patient of diabetes from insulin dependency. Our goal is to make a highly allocompatible and off-the-shelf product available to the millions of ...

The therapy ... US with type 1 diabetes. Other companies working in this area include Canadian group Sernova, which has a phase 1/2 trial on the go for islet cells in its proprietary Cell Pouch ...

According to Precedence Research, the global stem cell therapy market size was valued at USD 14.15 billion in 2023 and is expected to hit around USD 48.89 billion by 2033 with a CAGR of 13.2% from ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D ... FDA lifted a clinical hold on a phase 1/2 trial of VX-880 – a stem cell therapy Vertex acquired through its near ...

SR-02 is the first reprogrammed stem cell-derived pancreatic ... management of insulin-requiring diabetes and the associated life-threatening complications. Seraxis’ lead program, SR-02, is a novel ...

Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...

Type 1 diabetes ... results from mouse diabetes models validate these observations. “Here the authors demonstrate that ß cell differentiation from human pluripotent stem cells can be improved ...

Different trials involving stem cell therapy are on in India, but studies are long-term and risks like immune rejection need ...